Anti-NMDA receptor encephalitis epidemiology and demographics: Difference between revisions
| Line 10: | Line 10: | ||
*While 40% of cases are infectious and 40% are attributable to unknown causes, at least 20% are immune-mediated, with anti-NMDA-receptor encephalitis (4%) and VGK Complex antibody-positive encephalitis (3%) constituting the major categories. | *While 40% of cases are infectious and 40% are attributable to unknown causes, at least 20% are immune-mediated, with anti-NMDA-receptor encephalitis (4%) and VGK Complex antibody-positive encephalitis (3%) constituting the major categories. | ||
*The condition is more prevalent among women (81%) and younger patients (37% 18 years, 95% 45 years); however, in the age categories younger than 12 years and older than 45 years, the disease is more prevalent among men nearly half of patients are male. | |||
==References== | ==References== | ||
Revision as of 06:07, 21 January 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis epidemiology and demographics |
|
FDA on Anti-NMDA receptor encephalitis epidemiology and demographics |
|
CDC on Anti-NMDA receptor encephalitis epidemiology and demographics |
|
Anti-NMDA receptor encephalitis epidemiology and demographics in the news |
|
Blogs on Anti-NMDA receptor encephalitis epidemiology and demographics |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; AE Dheeraj Makkar, M.D.[2]
Overview
Epidemiology and Demographics
Encephalitis due to any cause has a yearly incidence of 2–3 per 100,000 in northern Europe, which is half the incidence of multiple sclerosis (4–8 per 100,000 annually).
- While 40% of cases are infectious and 40% are attributable to unknown causes, at least 20% are immune-mediated, with anti-NMDA-receptor encephalitis (4%) and VGK Complex antibody-positive encephalitis (3%) constituting the major categories.
- The condition is more prevalent among women (81%) and younger patients (37% 18 years, 95% 45 years); however, in the age categories younger than 12 years and older than 45 years, the disease is more prevalent among men nearly half of patients are male.